美国非显而易见性判定实践的误区和难点

非显而易见性要求是专利诉讼焦点之一,也是判定实践的难点之一,特别是对生物技术等一些新兴的领域。2009年Kubin案对非显而易见性的判定结果引发了关于基因专利非显而易见性的激烈讨论。通过结合相关实践案例分析,指出美国专利非显而易见性的判定实践的误区和难点。

Pitfalls and Difficulties of Determination of Nonobviousness in the United States

Nonobviousness is one of the focus in patent proceedings. And its determination is very difficult for the courts, especially in some emerging fields such as biological technology. In 2009, the decision of In re Kubin triggered intense discuss of nonobviousness determination in gene patents. Here, the author analyses the pitfalls and difficulties of determination of nonobviousness in practice with related cases.